Drug Type Small molecule drug |
Synonyms NSC23766 |
Target |
Action inhibitors |
Mechanism RAC1 inhibitors(Rac family small GTPase 1 inhibitors), TIAM1 inhibitors(TIAM Rac1 associated GEF 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H35N7 |
InChIKeyDEFBCZWQLILOJF-UHFFFAOYSA-N |
CAS Registry733767-34-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Hyperplasia | Preclinical | - | - | 01 Apr 2014 |
Prostatic Cancer | Preclinical | United States | 05 May 2004 |